Kurome Therapeutics
Cincinnati
About Kurome Therapeutics
Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy. The company is developing therapies that target cancer cells that have co-opted immune signaling pathways to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2021)
- Website: kurometherapeutics.com
- Phone: 513-445-3852
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kurome-therapeutics-33016 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.